
P1318: THE IMPACT OF MELPHALAN DOSING IN COMBINATION WITH FLUDARABINE IN CLINICAL OUTCOMES OF PATIENTS WITH ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROMES RECEIVING ALLO‐HCT
Author(s) -
Albanyan O.,
Kalos D.,
Kim J.,
Faramand R.,
Elmariah H.,
Mishra A.,
Nishihori T.,
Perez L.,
Nieder M.,
Pidala J.,
Bejnayan N.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000848136.92177.cc
Subject(s) - medicine , fludarabine , mucositis , melphalan , gastroenterology , myelodysplastic syndromes , dosing , surgery , myeloid leukemia , regimen , toxicity , transplantation , chemotherapy , cyclophosphamide , bone marrow